Ascorbic Acid Augments Arsenic-Mediated Cell Death in Multiple Myeloma (MM) Cells

Ascorbic Acid Augments Arsenic-Mediated Cell Death in Multiple Myeloma (MM) Cells

Saved in:

Bibliographic Details
Main Authors:	Jennifer M. Grad, Nizar J. Bahlis, Lawrence H. Boise
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/tsw.2001.123
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multiple Myeloma with Foamy Mott Cells
by: Karen Nalbandyan, et al.
Published: (2021-01-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

A review on the potential of Bruton’s tyrosine kinase (Btk) inhibitor – Ibrutinib for treatment of Multiple Myeloma (MM)
by: Sze-Ting Bong, et al.
Published: (2019-05-01)

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
by: Ugo Testa, et al.
Published: (2024-10-01)

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
by: Liesbeth Bieghs, et al.
Published: (2010-01-01)

Conversion from a Type I to a Type II Death Receptor-Mediated Pathway through A Partial Inhibition of Caspase-8
by: Bryan W. Johnson, et al.
Published: (2001-01-01)

Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma
by: Son Tran, et al.
Published: (2025-02-01)

RNA Viruses: ROS-Mediated Cell Death
by: Mohammad Latif Reshi, et al.
Published: (2014-01-01)

Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells
by: Nicolas Espagnolle, et al.
Published: (2020-01-01)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
by: Zeina Al-Mansour, et al.
Published: (2014-01-01)

Stem Cells for Augmenting Tendon Repair
by: Lawrence V. Gulotta, et al.
Published: (2012-01-01)

Serum Proinflammatory Mediators at Different Periods of Therapy in Patients With Multiple Myeloma
by: Irfan Kuku, et al.
Published: (2005-01-01)

PCMMD: A Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple Myeloma
by: Caio L. B. Andrade, et al.
Published: (2025-01-01)

Thromboprophylaxis in multiple myeloma
by: Laurent Frenzel
Published: (2025-01-01)

Multiple Myeloma of the Orbit
by: Mona Hassan, et al.
Published: (2012-01-01)

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study)
by: Annemarie Glöckner, et al.
Published: (2025-01-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

Cell Death
by: Claudia Giampietri, et al.
Published: (2014-01-01)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc
by: Ines Mrakovcic-Šutic, et al.
Published: (2002-01-01)

Cellular rejuvenation protects neurons from inflammation-mediated cell death
by: Sienna S. Drake, et al.
Published: (2025-02-01)

Unraveling TGF-β1’s Role in Mediating Fibrosis and Cell Death in Feline Kidney Cells
by: Chanyanuch Intachat, et al.
Published: (2025-01-01)

A 37 mm Spindle Cell Lipoma on the Floor of the Mouth
by: Eve Malthiery, et al.
Published: (2019-01-01)

Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity
by: Julia Petersson, et al.
Published: (2021-01-01)

Synchronous Diagnosis of Multiple Myeloma, Breast Cancer, and Monoclonal B-Cell Lymphocytosis on Initial Presentation
by: A. Vennepureddy, et al.
Published: (2016-01-01)

Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role
by: Giovanni D’Arena, et al.
Published: (2016-01-01)

Cell Stress and Cell Death
by: Afshin Samali, et al.
Published: (2010-01-01)

Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes
by: Yan-Hua Wang, et al.
Published: (2024-01-01)

In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells
by: Jovičić Marijana Šimić, et al.
Published: (2022-12-01)

Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration?
by: Giuseppe Mele, et al.
Published: (2013-01-01)

The Evolution of Prognostic Factors in Multiple Myeloma
by: Amr Hanbali, et al.
Published: (2017-01-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Regulatory T Cells Resist Cyclosporine-Induced Cell Death via CD44-Mediated Signaling Pathways
by: Shannon M. Ruppert, et al.
Published: (2015-01-01)

Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads
by: Yu Jeong Choi, et al.
Published: (2025-01-01)

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
by: P. Joy Ho, et al.
Published: (2025-01-01)

Load Balancing for Integrated Access and Backhaul in mmWave Small Cells
by: Quang-Huy Tran, et al.
Published: (2023-01-01)

Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review
by: Rui Bergantim, et al.
Published: (2020-01-01)

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
by: Marie Törngren, et al.
Published: (2023-01-01)

Relapse of Multiple Myeloma Presenting as Extramedullary Plasmacytomas in Multiple Organs
by: Murat Köse, et al.
Published: (2015-01-01)

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
by: Ka-Won Kang, et al.
Published: (2025-02-01)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01)